NCT06954610View on ClinicalTrials.gov

Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions

Ischemic StrokeAtrial FibrillationCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesArrhythmias, CardiacHeart DiseasesBrain InfarctionBrain IschemiaInfarction CerebralStrokeCardioembolic StrokeIschemia

Interventions

OTHER

No intervention

Trial Locations (1)

3010

Inselspital Bern, Bern

All Listed Sponsors

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT06954610 - Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation | Biotech Hunter | Biotech Hunter